When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
XENT - Intersect ENT gets second request from FTC for planned sale to Medtronic
Intersect ENT Inc.
Intersect ENT (NASDAQ:XENT) received a "second request" from the Federal Trade Commission on Sept. 22 regarding its planned sale to Medtronic (NYSE:MDT) according to 8-K filing yesterday. Intersect (XENT) believes its sale remains on track to close toward the end of Medtronic's fiscal year on April 30. Recall August, Medtronic to acquire implant manufacturer Intersect ENT for $1.1 billion. Yesterday, Intersect ENT EPS misses by $0.06, misses on revenue.